advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (8)
Showing records 1 to 8
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation19834 Effect of anti-glaucoma topical medications on expression of TGF-β and MMP of human Tenons fibroblast
Zhang J-Y; Leng F; Peng S-M
International Journal of Ophthalmology 2007; 7: 1294-1297
19691 Ocular side effects of glaucoma treatment agents
Ehongo A; Bremer F
Bulletin de la Société Belge d'Ophtalmologie 2007; 304: 103-110
19775 Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Molecular Vision 2007; 13: 1783-1792
19757 Immobilization of drugs for glaucoma treatment
Almeida JF; Fonseca A; Baptista CMSG; Leite E; Gil MH
Journal of Materials Science: Materials in Medicine 2007; 18: 2309-2317
19677 Timolol transport from microemulsions trapped in HEMA gels
Li C-C; Abrahamson M; Kapoor Y; Chauhan A
Journal of Colloid and Interface Science 2007; 315: 297-306
19710 Effects of topical antiglaucoma medications on corneal epithelium as evaluated by gene expression patterns
Okada Y
Cornea 2007; 26: S46-S54
19693 Medical applications of poly(styrene-block-isobutylene-block-styrene) ('SIBS')
Pinchuk L; Wilson GJ; Barry JJ; Schoephoerster RT; Parel J-M; Kennedy JP
Biomaterials 2008; 29: 448-460
19816 Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study
Nordmann JP; Denis P; Vigneux M; Trudeau E; Guillemin I; Berdeaux G
BMC Health Services Research 2007; 7: Article Number: 124